Concepedia

Kevin Bowman

KB

Statistics

Publications

17

Citations

2.2K

H-Index

14

Active since

1974

Affiliations

Incyte (United States)(Current)

University of Chicago

University of Pennsylvania

Kevin Bowman is an author at Incyte (United States) specializing in medicine, pharmacology, and tumor biology.

Top concepts

Publications per year

1974–2021

17

Publications

17

Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity

Xiangdong Liu, Niu Shin, Holly K. Koblish et al. · Blood · 2010 · 552 citations · Full text

First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies

Gregory L. Beatty, Peter J. O’Dwyer, Jason Clark et al. · Clinical Cancer Research · 2017 · 310 citations · Full text

INCB24360 (Epacadostat), a Highly Potent and Selective Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitor for Immuno-oncology

Eddy W. Yue, Richard Sparks, Padmaja Polam et al. · ACS Medicinal Chemistry Letters · 2017 · 290 citations · Full text

Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors

Holly K. Koblish, Michael Hansbury, Kevin Bowman et al. · Molecular Cancer Therapeutics · 2010 · 243 citations · Full text

Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model

Eddy W. Yue, Brent Douty, Brian Wayland et al. · Journal of Medicinal Chemistry · 2009 · 216 citations · Full text

, , +17

1–5 of 17